Literature DB >> 21615099

Acetoxy Meldrum's acid: a versatile acyl anion equivalent in the Pd-catalyzed asymmetric allylic alkylation.

Barry M Trost1, Maksim Osipov, Philip S J Kaib, Mark T Sorum.   

Abstract

Acetoxy Meldrum's acid can serve as a versatile acyl anion equivalent in the Pd-catalyzed asymmetric allylic alkylation. The reaction of this nucleophile with various meso and racemic electrophiles afforded alkylated products in high yields and enantiopurities. These enantioenriched products are versatile intermediates that can be further functionalized using nitrogen- and oxygen-centered nucleophiles, affording versatile scaffolds for the synthesis of nucleoside analogues. These scaffolds were used to complete formal syntheses of the anti-HIV drugs carbovir, abacavir, and the antibiotic aristeromycin.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615099      PMCID: PMC3144701          DOI: 10.1021/ol2011242

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  19 in total

1.  Asymmetric transition-metal-catalyzed allylic alkylations: applications in total synthesis.

Authors:  Barry M Trost; Matthew L Crawley
Journal:  Chem Rev       Date:  2003-08       Impact factor: 60.622

Review 2.  L-nucleoside enantiomers as antivirals drugs: a mini-review.

Authors:  Christophe Mathé; Gilles Gosselin
Journal:  Antiviral Res       Date:  2006-05-23       Impact factor: 5.970

Review 3.  Emerging of HIV drug resistance: epidemiology, diagnosis, treatment and prevention.

Authors:  Sasisopin Kiertiburanakul; Somnuek Sungkanuparph
Journal:  Curr HIV Res       Date:  2009-05       Impact factor: 1.581

4.  Synthesis of cyclopentitols by ring-closing approaches.

Authors:  Vanya B Kurteva; Carlos A M Afonso
Journal:  Chem Rev       Date:  2009-12       Impact factor: 60.622

5.  An efficient, scalable synthesis of the HIV reverse transcriptase inhibitor Ziagen (1592U89).

Authors:  S M Daluge; M T Martin; B R Sickles; D A Livingston
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2000 Jan-Feb       Impact factor: 1.381

6.  Predicting the stereochemistry of diphenylphosphino benzoic acid (DPPBA)-based palladium-catalyzed asymmetric allylic alkylation reactions: a working model.

Authors:  Barry M Trost; Michelle R Machacek; Aaron Aponick
Journal:  Acc Chem Res       Date:  2006-10       Impact factor: 22.384

Review 7.  Antiviral activities of isometric dideoxynucleosides of D- and L-related stereochemistry.

Authors:  V Nair; T S Jahnke
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

8.  A Versatile Enantioselective Strategy Toward L-C-Nucleosides: A Total Synthesis of L-Showdomycin.

Authors:  Barry M. Trost; Lara S. Kallander
Journal:  J Org Chem       Date:  1999-07-23       Impact factor: 4.354

Review 9.  Carbocyclic nucleosides (carbanucleosides) as new therapeutic leads.

Authors:  Stewart W Schneller
Journal:  Curr Top Med Chem       Date:  2002-10       Impact factor: 3.295

10.  Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosides.

Authors:  R Vince; M Hua
Journal:  J Med Chem       Date:  1990-01       Impact factor: 7.446

View more
  3 in total

1.  Palladium-catalyzed asymmetric allylic alkylation of electron-deficient pyrroles with meso electrophiles.

Authors:  Barry M Trost; Maksim Osipov; Guangbin Dong
Journal:  Org Lett       Date:  2012-04-16       Impact factor: 6.005

2.  Cu(II)-catalyzed aerobic hydroperoxidation of Meldrum's acid derivatives and application in intramolecular oxidation: a conceptual blueprint for O2/H2 dihydroxylation.

Authors:  Scott W Krabbe; Dung T Do; Jeffrey S Johnson
Journal:  Org Lett       Date:  2012-11-19       Impact factor: 6.005

3.  Regio- and stereospecific rhodium-catalyzed allylic alkylation with an acyl anion equivalent: an approach to acyclic α-ternary β,γ-unsaturated aryl ketones.

Authors:  Ben W H Turnbull; Jungha Chae; Samuel Oliver; P Andrew Evans
Journal:  Chem Sci       Date:  2017-03-31       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.